What is the optimal therapy for patients with H5N1 influenza?
about
Platelet-activating factor receptor plays a role in lung injury and death caused by Influenza A in miceNanobodies with in vitro neutralizing activity protect mice against H5N1 influenza virus infectionEthics of clinical science in a public health emergency: drug discovery at the bedsideAntiviral susceptibility of highly pathogenic avian influenza A(H5N1) viruses isolated from poultry, Vietnam, 2009-2011.Logistical feasibility and potential benefits of a population-wide passive-immunotherapy program during an influenza pandemicPerspectives on influenza evolution and the role of research.Intranasal delivery of an IgA monoclonal antibody effective against sublethal H5N1 influenza virus infection in miceFailure of combination oral oseltamivir and inhaled zanamivir antiviral treatment in ventilator- and ECMO-treated critically ill patients with pandemic influenza A (H1N1)v.Towards universal influenza vaccines?Oseltamivir resistance in swine influenza: a brief discussion.Within-Host Models of High and Low Pathogenic Influenza Virus Infections: The Role of MacrophagesMitochondrion-Permeable Antioxidants to Treat ROS-Burst-Mediated Acute Diseases.Predicting Disease Severity and Viral Spread of H5N1 Influenza Virus in Ferrets in the Context of Natural Exposure Routes.Clinical findings for early human cases of influenza A(H7N9) virus infection, Shanghai, China.6th International Conference on Emerging Zoonoses.Animal models in virus research: their utility and limitations.Pharmacokinetic properties of anti-influenza neuraminidase inhibitors.Drugs to cure avian influenza infection--multiple ways to prevent cell deathA Critical Role for Immune System Response in Mediating Anti-influenza Drug Synergies Assessed by Mechanistic ModelingCommentary: A Historical Review of Centers for Disease Control and Prevention Antiviral Treatment and Postexposure Chemoprophylaxis Guidance for Human Infections With Novel Influenza A Viruses Associated With Severe Human Disease.Zanamivir for the treatment of avian influenza infections in humans.Swine influenza (H1N1): diagnostic dilemmas early in the pandemic.
P2860
Q27312687-CABC08BA-24D0-43D9-AF4A-45197DFB30A0Q28308105-3288DBE3-D36E-41AF-8476-7E2F5BE2419FQ28656104-1606F53B-448C-4E37-90DA-5C9EA06582D2Q30218773-15245B0C-1D4E-41A4-87E4-8310C4A3CD5BQ30385394-43005ECB-ADF8-4F1F-894E-C93DD31E503EQ30390922-47B9E323-2709-4533-BFF3-3529A78EF55DQ30391974-E4934AE0-5D07-4F19-97AD-DD795EEA63F6Q30399530-719DA684-08F2-44C6-B9CB-EE0066F92CF4Q30406748-D64F0DDF-955F-44B7-8610-98608865885BQ30417566-8114CEF6-B8BB-443D-8014-1CC9090FF29CQ35936916-B886592D-0A34-4172-83DA-37DB6BA9C73EQ36329020-6AE7178D-92BE-4A6F-A4BC-3643B056AE72Q36523909-7417C11A-2C2F-4F81-A8B1-C21F1D431C83Q37021136-9D8F3156-E118-42B3-B4A6-5518269275E4Q38041653-D29282C7-AB54-4C86-BC09-9FEEBB4C032AQ38043556-DB9C36EC-0506-4162-90AE-7122885617F9Q38084212-2FEC5377-F6D7-49B4-8F56-E91CC23D55D6Q38148960-7D0C7E45-F403-42A6-952C-191F64F92DEDQ41745036-8FD77217-01A8-420E-BA61-3293F7CF8202Q41932743-AF6ED095-BE70-43DE-92FD-BF550ADBAE64Q42723628-FE413AEA-C9E8-46D1-8118-3803F578A664Q54454024-9BF5EF83-2294-4040-B954-19E0BD9628B1
P2860
What is the optimal therapy for patients with H5N1 influenza?
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
What is the optimal therapy for patients with H5N1 influenza?
@ast
What is the optimal therapy for patients with H5N1 influenza?
@en
What is the optimal therapy for patients with H5N1 influenza?
@nl
type
label
What is the optimal therapy for patients with H5N1 influenza?
@ast
What is the optimal therapy for patients with H5N1 influenza?
@en
What is the optimal therapy for patients with H5N1 influenza?
@nl
prefLabel
What is the optimal therapy for patients with H5N1 influenza?
@ast
What is the optimal therapy for patients with H5N1 influenza?
@en
What is the optimal therapy for patients with H5N1 influenza?
@nl
P2860
P50
P1433
P1476
What is the optimal therapy for patients with H5N1 influenza?
@en
P2860
P304
P356
10.1371/JOURNAL.PMED.1000091
P407
P577
2009-06-23T00:00:00Z